Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperlipoproteinemia (a)”

521 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 521 results

Early research (Phase 1)Study completedNCT01764178
What this trial is testing

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

Who this might be right for
HyperlipidemiaHypertension
JW Pharmaceutical 52
Not applicableUnknownNCT03398954
What this trial is testing

A Prospective Pilot Study of Screening Out Rate and Clinical Management of Familial Hypercholesterolemia

Who this might be right for
Familial Hypercholesterolemia
China Cardiovascular Association 1,128
Not applicableStudy completedNCT06692777
What this trial is testing

Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial.

Who this might be right for
Hyperlipidemia
Chung Shan Medical University 120
Early research (Phase 1)Study completedNCT05398029
What this trial is testing

VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaAtherosclerotic Cardiovascular DiseaseHypercholesterolemia
Verve Therapeutics, Inc. 13
Not applicableStudy completedNCT04148001
What this trial is testing

Identifying and Genotyping Homozygous Familial Hypercholesterolemia (HoFH) Patients

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 4
Not applicableWithdrawnNCT05720156
What this trial is testing

Immunomodulatory Effects of PCSK9 Inhibition

Who this might be right for
Atherosclerotic Cardiovascular DiseaseCardiovascular DiseasesAtherosclerosis+12 more
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT04270760
What this trial is testing

Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study

Who this might be right for
Cardiovascular Disease
Amgen 281
Large-scale testing (Phase 3)Active Not RecruitingNCT05739383
What this trial is testing

Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

Who this might be right for
Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals 14,012
Testing effectiveness (Phase 2)Study completedNCT02659397
What this trial is testing

Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mg

Who this might be right for
Hyperlipidemia
Esperion Therapeutics, Inc. 68
Early research (Phase 1)Study completedNCT02449187
What this trial is testing

Investigate the Effect of Food on the Pharmacokinetics of JLP-1310 in Healthy Male Volunteers

Who this might be right for
DiabetesHyperlipidemia
Jeil Pharmaceutical Co., Ltd. 16
Large-scale testing (Phase 3)Study completedNCT02658175
What this trial is testing

The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia SyndromeLipoprotein Lipase DeficiencyHyperlipoproteinemia Type 1
Akcea Therapeutics 68
Early research (Phase 1)Study completedNCT02982798
What this trial is testing

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

Who this might be right for
DiabetesHyperlipidemia
Jeil Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT05395143
What this trial is testing

Study to Assess the Effect of Zinc in Atorvastatin Treated Hyperlipidemic Patients

Who this might be right for
Hyperlipidemias
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 92
Large-scale testing (Phase 3)Ended earlyNCT00231621
What this trial is testing

A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

Who this might be right for
ObesityHyperlipidemiaHypertriglyceridemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 179
Large-scale testing (Phase 3)Not Yet RecruitingNCT07421284
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia on a Background of Lipid-lowering Therapy

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 900
Large-scale testing (Phase 3)Active Not RecruitingNCT05900141
What this trial is testing

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Who this might be right for
Hyperlipoproteinemia (a)
Novartis Pharmaceuticals 41
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Large-scale testing (Phase 3)Study completedNCT00006412
What this trial is testing

Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood Lipids

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 630
Large-scale testing (Phase 3)Study completedNCT00236600
What this trial is testing

A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program

Who this might be right for
Obesity
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 561
Post-approval studies (Phase 4)UnknownNCT02992301
What this trial is testing

Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab

Who this might be right for
AtherosclerosisHyperlipidemia
Westside Medical Associates of Los Angeles 35
Load More Results